← Leaderboards
John Digiovanni
University Of Texas At Austin
$26,040,423
Attributed
$33,668,523
Total exposure
21
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,163,963 · 22
By mechanism
R01$30,021,969 · 15
P30$13,613,292 · 5
P50$1,159,060 · 1
R21$369,642 · 1
Top collaborators
- Thomas J Slaga8 shared
- Karen M Vasquez7 shared
- George Georgiou Georgiou5 shared
- Mikhail G Kolonin5 shared
- Cherie-Ann O Nathan5 shared
- Everett Stone5 shared
- Stefano Tiziani5 shared
Others in their field
Top investigators on “Skin Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,104,269
- Elaine Fuchs · University Of Chicago$26,726,187
- Allan Balmain · University Of California San Francisco$25,703,743
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- Larry Arthur$22,931,757
- Janet Ellen Dancey · Queen'S University At Kingston$22,425,599
Research focus
Skin NeoplasmsBaseLeadTissuesMalignant NeoplasmsPlayTumorKeratinocyteMouse ModelEpidermisTumor PromotionCarcinogenesisResponseSignal PathwayGeneticPreventIn VivoTransgenic MiceSignal TransductionSkin CarcinogenesisGrowthPathway InteractionsResearch StudyStaging
Grant awards (114)
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma$362,569
R01 · FY2025 · CA · contact PI
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma$344,441
R01 · FY2024 · CA · contact PI
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$491,916
R01 · FY2023 · CA · contact PI
Molecular mechanisms of thermogenesis$422,000
R01 · FY2023 · DK · contact PI
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma$355,317
R01 · FY2023 · CA · contact PI
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$491,916
R01 · FY2022 · CA · contact PI
Mechanisms of Obesity-Induced Genetic Instability at Endogenous Mutation Hotspots$427,091
R01 · FY2022 · CA
Molecular mechanisms of thermogenesis$422,000
R01 · FY2022 · DK · contact PI
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.$383,159
R01 · FY2022 · CA
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma$355,317
R01 · FY2022 · CA · contact PI
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$501,955
R01 · FY2021 · CA · contact PI
Mechanisms of Obesity-Induced Genetic Instability at Endogenous Mutation Hotspots$435,807
R01 · FY2021 · CA
Molecular mechanisms of thermogenesis$422,000
R01 · FY2021 · DK · contact PI
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.$386,483
R01 · FY2021 · CA
Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma$362,569
R01 · FY2021 · CA · contact PI
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$501,955
R01 · FY2020 · CA · contact PI
Molecular mechanisms of thermogenesis$436,625
R01 · FY2020 · DK · contact PI
Mechanisms of Obesity-Induced Genetic Instability at Endogenous Mutation Hotspots$435,807
R01 · FY2020 · CA
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.$388,890
R01 · FY2020 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$501,955
R01 · FY2019 · CA · contact PI
Mechanisms of Obesity-Induced Genetic Instability at Endogenous Mutation Hotspots$445,583
R01 · FY2019 · CA
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.$385,203
R01 · FY2019 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression$384,412
R01 · FY2019 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2018 · CA
Mechanisms of Obesity-Induced Genetic Instability at Endogenous Mutation Hotspots$459,365
R01 · FY2018 · CA
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.$399,821
R01 · FY2018 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression$396,302
R01 · FY2018 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2017 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression$396,302
R01 · FY2017 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2016 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$485,169
R01 · FY2016 · CA · contact PI
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression$396,302
R01 · FY2016 · CA · contact PI
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$54,438
R01 · FY2016 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2015 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$436,181
R01 · FY2015 · CA · contact PI
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression$407,569
R01 · FY2015 · CA · contact PI
(PQA2) Impact of obesity on endogenous mutational hotspots$168,019
R21 · FY2015 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$54,438
R01 · FY2015 · CA · contact PI
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.$580,448
R01 · FY2014 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$428,277
R01 · FY2014 · CA · contact PI
(PQA2) Impact of obesity on endogenous mutational hotspots$201,623
R21 · FY2014 · CA
Anti-promoting effects of Triterpenes alone or combined with other phytochemicals$50,875
R01 · FY2014 · CA · contact PI
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$422,290
R01 · FY2013 · CA · contact PI
Identification of Tumor Promotion Susceptibility Genes$328,492
R01 · FY2013 · ES · contact PI
Obesity, Prostate Cancer Progresion and Akt/mTOR Signaling$219,666
P50 · FY2013 · CA · contact PI
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$467,444
R01 · FY2012 · CA · contact PI
Identification of Tumor Promotion Susceptibility Genes$335,195
R01 · FY2012 · ES · contact PI
Stat3 in Epitherlial Carcinogenesis$299,504
R01 · FY2012 · CA · contact PI
Obesity, Prostate Cancer Progresion and Akt/mTOR Signaling$240,955
P50 · FY2012 · CA · contact PI
Identification of Tumor Promotion Susceptibility Genes$335,195
R01 · FY2011 · ES · contact PI
Pilot Project Program$310,613
P30 · FY2011 · ES · contact PI
Stat3 in Epitherlial Carcinogenesis$300,513
R01 · FY2011 · CA · contact PI
Obesity, Prostate Cancer Progresion and Akt/mTOR Signaling$231,200
P50 · FY2011 · CA · contact PI
Career Development of Environmental Health Investigators$23,234
P30 · FY2011 · ES · contact PI
Identification of common pathways in tumor promotion$419,538
R01 · FY2010 · ES · contact PI
Akt Signaling Pathways in Epithelial Carcinogenesis$344,692
R01 · FY2010 · CA · contact PI
Identification of Tumor Promotion Susceptibility Genes$338,580
R01 · FY2010 · ES · contact PI
Pilot Project Program$322,964
P30 · FY2010 · ES · contact PI
Stat3 in Epitherlial Carcinogenesis$305,647
R01 · FY2010 · CA · contact PI
Obesity, Prostate Cancer Progresion and Akt/mTOR Signaling$233,624
P50 · FY2010 · CA · contact PI
Career Development of Environmental Health Investigators$23,454
P30 · FY2010 · ES · contact PI
Akt Signaling Pathways in Epithelial Carcinogenesis$353,442
R01 · FY2009 · CA · contact PI
Identification of Tumor Promotion Susceptibility Genes$346,500
R01 · FY2009 · ES · contact PI
Pilot Project Program$324,195
P30 · FY2009 · ES · contact PI
Stat3 in Epitherlial Carcinogenesis$318,098
R01 · FY2009 · CA · contact PI
Identification of common pathways in tumor promotion$285,108
R01 · FY2009 · ES · contact PI
Obesity, Prostate Cancer Progresion and Akt/mTOR Signaling$233,615
P50 · FY2009 · CA · contact PI
Identification of common pathways in tumor promotion$148,233
R01 · FY2009 · ES · contact PI
Career Development of Environmental Health Investigators$22,856
P30 · FY2009 · ES · contact PI
Mechanisms and Prevention of Environmental Disease$1,664,327
P30 · FY2008 · ES · contact PI
Identification of common pathways in tumor promotion$433,381
R01 · FY2008 · ES · contact PI
Pilot Project Program$326,701
P30 · FY2008 · ES · contact PI
Career Development of Environmental Health Investigators$22,297
P30 · FY2008 · ES · contact PI
Mechanisms and Prevention of Environmental Disease$1,727,029
P30 · FY2007 · ES · contact PI
Identification of common pathways in tumor promotion$441,792
R01 · FY2007 · ES · contact PI
Mechanisms of IGF-1 Tumor Promotion in Mouse Skin$336,463
R01 · FY2007 · CA · contact PI
Novel therapies for biliary cancers in BK5.erbB-2 mice$318,565
R01 · FY2007 · CA · contact PI
Tyrosine Kinases and c-src in Skin Cancer$302,817
R01 · FY2007 · CA · contact PI
Pilot Project Program$282,170
P30 · FY2007 · ES · contact PI
Administrative Core$250,617
P30 · FY2007 · ES · contact PI
Career Development of Environmental Health Investigators$18,746
P30 · FY2007 · ES · contact PI
Mechanisms of IGF-1 Tumor Promotion in Mouse Skin$346,512
R01 · FY2006 · CA · contact PI
Novel therapies for biliary cancers in BK5.erbB-2 mice$328,079
R01 · FY2006 · CA · contact PI
Tyrosine Kinases and c-src in Skin Cancer$311,860
R01 · FY2006 · CA · contact PI
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$1,408,068
P30 · FY2005 · ES
Mechanisms of IGF-1 Tumor Promotion in Mouse Skin$354,850
R01 · FY2005 · CA
Novel therapies for biliary cancers in BK5.erbB-2 mice$335,975
R01 · FY2005 · CA
Tyrosine Kinases and c-src in Skin Cancer$319,365
R01 · FY2005 · CA
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$1,398,427
P30 · FY2004 · ES
Mechanisms of IGF-1 Tumor Promotion in Mouse Skin$354,850
R01 · FY2004 · CA
Novel therapies for biliary cancers in BK5.erbB-2 mice$335,975
R01 · FY2004 · CA
Tyrosine Kinases and c-src in Skin Cancer$319,365
R01 · FY2004 · CA
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$1,408,165
P30 · FY2003 · ES
Mechanisms of IGF-1 Tumor Promotion in Mouse Skin$354,850
R01 · FY2003 · CA
Novel therapies for biliary cancers in BK5.erbB-2 mice$335,975
R01 · FY2003 · CA
Tyrosine Kinases and c-src in Skin Cancer$319,365
R01 · FY2003 · CA
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$1,398,351
P30 · FY2002 · ES
TYROSINE KINASES AND C SRC IN SKIN CANCER$320,220
R01 · FY2002 · CA
NATURAL &SYNTHETIC COUMARINS AS ANTICARCINOGENIC AGENTS$217,587
R01 · FY2002 · CA
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$1,388,691
P30 · FY2001 · ES
TYROSINE KINASES AND C SRC IN SKIN CANCER$234,263
R01 · FY2001 · CA
NATURAL &SYNTHETIC COUMARINS AS ANTICARCINOGENIC AGENTS$211,862
R01 · FY2001 · CA
IDENTIFICATION OF TUMOR PROMOTION SUSCEPTIBILITY GENES$191,142
R01 · FY2001 · ES
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$92,175
P30 · FY2001 · ES
TYROSINE KINASES AND C SRC IN SKIN CANCER$77,190
R01 · FY2001 · CA
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$900,207
P30 · FY2000 · ES
MECHANISM OF MOUSE SKIN TUMOR PROMOTION BY CHRYSAROBIN$364,130
R01 · FY2000 · CA
TYROSINE KINASES AND C SRC IN SKIN CANCER$227,999
R01 · FY2000 · CA
NATURAL &SYNTHETIC COUMARINS AS ANTICARCINOGENIC AGENTS$206,301
R01 · FY2000 · CA
IDENTIFICATION OF TUMOR PROMOTION SUSCEPTIBILITY GENES$185,574
R01 · FY2000 · ES
PILOT PROJECT--MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$117,873
P30 · FY2000 · ES
MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$110,000
P30 · FY2000 · ES
TYROSINE KINASES AND C SRC IN SKIN CANCER$74,942
R01 · FY2000 · CA
PILOT PROJECT--MECHANISMS AND PREVENTION OF ENVIRONMENTAL DISEASE$72,132
P30 · FY2000 · ES